Sort
48,018 grants matching “immunotherapy”
Immunogenic Priming with Lu-PSMA Targeted Therapy in Advanced Prostate Cancer
$368,455Rahul Aggarwal · University Of California, San Francisco · R01 · FY2020 · CA
RP-1: Defining Predictors of Sensitivity to Cisplatin-Based Chemotherapy in Urothelial Cancer
$368,437David B. Solit · Sloan-Kettering Inst Can Research · P50 · FY2021 · CA
Role of immune modulating butyrophilins in gamma delta T cell activation
$368,411Andrew J Wiemer · University Of Connecticut Storrs · R01 · FY2024 · AI
Project 3: Modulation of the head and neck tumor immune microenvironment by targeting the TAM family of receptors
$368,400Deric L Wheeler · University Of Wisconsin-Madison · P50 · FY2024 · CA
Intra and Extra-Chromosomal Probes for Mutagenesis by Carcinogens
$368,363John M Essigmann · Massachusetts Institute Of Technology · R01 · FY2024 · CA
Potentiating Checkpoint Blockade by Cross-Priming Tumor-Reactive T cells with In Situ Vaccination
$368,346Joshua D Brody · Icahn School Of Medicine At Mount Sinai · R37 · FY2024 · CA
Project 5
$368,313Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2008 · CA
Next generation platforms for interrogating TCR specificity
$368,294Kenan Christopher Garcia · Stanford University · R33 · FY2025 · CA
Macrophage-based Therapy and Immune Checkpoint Blockade for Glioblastoma
$368,288Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · CA
Regulation of antigen presenting cells in the tumor microenvironment by retinoic acid
$368,288Malay Haldar · University Of Pennsylvania · R37 · FY2022 · CA
Macrophage-based Therapy and Immune Checkpoint Blockade for Glioblastoma
$368,288Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · CA
Targeting macrophages for immunotherapy in pancreatic cancer
$368,288Gregory L Beatty · University Of Pennsylvania · R01 · FY2016 · CA
The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells
$368,288Edmund K. Moon · University Of Pennsylvania · R01 · FY2017 · CA
The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells
$368,288Edmund K. Moon · University Of Pennsylvania · R01 · FY2018 · CA
Targeting macrophages for immunotherapy in pancreatic cancer
$368,288Gregory L Beatty · University Of Pennsylvania · R01 · FY2017 · CA
Regulation of antigen presenting cells in the tumor microenvironment by retinoic acid
$368,288Malay Haldar · University Of Pennsylvania · R37 · FY2021 · CA
Targeting macrophages for immunotherapy in pancreatic cancer
$368,288Gregory L Beatty · University Of Pennsylvania · R01 · FY2018 · CA
Determinants of prostate cancer sensitivity to PD-1 blockade
$368,288Lawrence Fong · University Of California, San Francisco · R01 · FY2021 · CA
Regulation of antigen presenting cells in the tumor microenvironment by retinoic acid
$368,288Malay Haldar · University Of Pennsylvania · R37 · FY2019 · CA
Cognate Activation of B-Lymphocytes
$368,288Randolph J. Noelle · Dartmouth College · R37 · FY2013 · AI
The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells
$368,288Edmund K. Moon · University Of Pennsylvania · R01 · FY2020 · CA
Regulation of antigen presenting cells in the tumor microenvironment by retinoic acid
$368,288Malay Haldar · University Of Pennsylvania · R37 · FY2020 · CA
The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells
$368,288Steven Mark Albelda · University Of Pennsylvania · R01 · FY2021 · CA
Targeting macrophages for immunotherapy in pancreatic cancer
$368,288Gregory L Beatty · University Of Pennsylvania · R01 · FY2020 · CA
Regulation Of Fitness And Virulence In Oral Streptococci
$368,285Ping Xu · Virginia Commonwealth University · R01 · FY2012 · DE